These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9537233

  • 21. A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy.
    Hall EJ, Schiff PB, Hanks GE, Brenner DJ, Russo J, Chen J, Sawant SG, Pandita TK.
    Cancer J Sci Am; 1998; 4(6):385-9. PubMed ID: 9853138
    [Abstract] [Full Text] [Related]

  • 22. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer.
    Izatt L, Greenman J, Hodgson S, Ellis D, Watts S, Scott G, Jacobs C, Liebmann R, Zvelebil MJ, Mathew C, Solomon E.
    Genes Chromosomes Cancer; 1999 Dec; 26(4):286-94. PubMed ID: 10534763
    [Abstract] [Full Text] [Related]

  • 23. [Ataxia telangiectasia: what impact in clinical oncology?].
    Stoppa-Lyonnet D, Aurias A.
    Bull Cancer; 1992 Dec; 79(7):645-50. PubMed ID: 1467590
    [Abstract] [Full Text] [Related]

  • 24. Cancer risk in heterozygotes for ataxia-telangiectasia.
    Geoffroy-Perez B, Janin N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D, Andrieu N.
    Int J Cancer; 2001 Jul 15; 93(2):288-93. PubMed ID: 11410879
    [Abstract] [Full Text] [Related]

  • 25. No evidence for constitutional ATM mutation in breast/gastric cancer families.
    Bay JO, Grancho M, Pernin D, Presneau N, Rio P, Tchirkov A, Uhrhammer N, Verrelle P, Gatti RA, Bignon YJ.
    Int J Oncol; 1998 Jun 15; 12(6):1385-90. PubMed ID: 9592204
    [Abstract] [Full Text] [Related]

  • 26. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
    Broeks A, Urbanus JH, Floore AN, Dahler EC, Klijn JG, Rutgers EJ, Devilee P, Russell NS, van Leeuwen FE, van 't Veer LJ.
    Am J Hum Genet; 2000 Feb 15; 66(2):494-500. PubMed ID: 10677309
    [Abstract] [Full Text] [Related]

  • 27. High incidence of gastrointestinal cancer in a family with ataxia-telangiectasia.
    Ceroni M, Karau J, Pergami P, Ferrandi D, Savoldi F.
    Acta Neurol (Napoli); 1994 Feb 15; 16(1-2):33-7. PubMed ID: 8073914
    [Abstract] [Full Text] [Related]

  • 28. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease.
    Nichols KE, Levitz S, Shannon KE, Wahrer DC, Bell DW, Chang G, Hegde S, Neuberg D, Shafman T, Tarbell NJ, Mauch P, Ishioka C, Haber DA, Diller L.
    J Clin Oncol; 1999 Apr 15; 17(4):1259. PubMed ID: 10561187
    [Abstract] [Full Text] [Related]

  • 29. Cancer risks in A-T heterozygotes.
    Easton DF.
    Int J Radiat Biol; 1994 Dec 15; 66(6 Suppl):S177-82. PubMed ID: 7836845
    [Abstract] [Full Text] [Related]

  • 30. Absence of linkage to the ataxia telangiectasia locus in familial breast cancer.
    Wooster R, Ford D, Mangion J, Ponder BA, Peto J, Easton DF, Stratton MR.
    Hum Genet; 1993 Aug 15; 92(1):91-4. PubMed ID: 8365732
    [Abstract] [Full Text] [Related]

  • 31. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain.
    Pippard EC, Hall AJ, Barker DJ, Bridges BA.
    Cancer Res; 1988 May 15; 48(10):2929-32. PubMed ID: 3359449
    [Abstract] [Full Text] [Related]

  • 32. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
    van Os NJ, Roeleveld N, Weemaes CM, Jongmans MC, Janssens GO, Taylor AM, Hoogerbrugge N, Willemsen MA.
    Clin Genet; 2016 Aug 15; 90(2):105-17. PubMed ID: 26662178
    [Abstract] [Full Text] [Related]

  • 33. Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations.
    Gatti RA, Tward A, Concannon P.
    Mol Genet Metab; 1999 Dec 15; 68(4):419-23. PubMed ID: 10607471
    [Abstract] [Full Text] [Related]

  • 34. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients.
    Shayeghi M, Seal S, Regan J, Collins N, Barfoot R, Rahman N, Ashton A, Moohan M, Wooster R, Owen R, Bliss JM, Stratton MR, Yarnold J.
    Br J Cancer; 1998 Oct 15; 78(7):922-7. PubMed ID: 9764584
    [Abstract] [Full Text] [Related]

  • 35. Whole genome joint analysis reveals ATM:C.1564_1565del variant segregating with Ataxia-Telangiectasia and breast cancer.
    Ćuk M, Unal B, Hayes CP, Walker M, Bevanda A, Antolović V, Ghazani AA.
    Cancer Genet; 2024 Aug 15; 286-287():43-47. PubMed ID: 39067332
    [Abstract] [Full Text] [Related]

  • 36. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia.
    Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, Moss PA, Taylor AM.
    Lancet; 1999 Jan 02; 353(9146):26-9. PubMed ID: 10023947
    [Abstract] [Full Text] [Related]

  • 37. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries.
    Olsen JH, Hahnemann JM, Børresen-Dale AL, Brøndum-Nielsen K, Hammarström L, Kleinerman R, Kääriäinen H, Lönnqvist T, Sankila R, Seersholm N, Tretli S, Yuen J, Boice JD, Tucker M.
    J Natl Cancer Inst; 2001 Jan 17; 93(2):121-7. PubMed ID: 11208881
    [Abstract] [Full Text] [Related]

  • 38. Malignant neoplasms in the families of patients with ataxia-telangiectasia.
    Swift M, Sholman L, Perry M, Chase C.
    Cancer Res; 1976 Jan 17; 36(1):209-15. PubMed ID: 1248000
    [Abstract] [Full Text] [Related]

  • 39. Risk of breast cancer in ataxia-telangiectasia.
    Hall EJ, Geard CR, Brenner DJ.
    N Engl J Med; 1992 May 14; 326(20):1358-9; author reply 1360-1. PubMed ID: 1565153
    [No Abstract] [Full Text] [Related]

  • 40. Cellular responses to radiation and risk of breast cancer.
    Jongmans W, Hall J.
    Eur J Cancer; 1999 Apr 14; 35(4):540-8. PubMed ID: 10492625
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.